13,789 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by Capital Fund Management S.A.

Capital Fund Management S.A. purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 13,789 shares of the company's stock, valued at approximately $547,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Raymond James Financial Inc. acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth $5,134,000. Cerity Partners LLC grew its position in shares of Acadia Healthcare by 52.1% during the 4th quarter. Cerity Partners LLC now owns 50,060 shares of the company's stock valued at $1,985,000 after buying an additional 17,138 shares during the last quarter. FMR LLC lifted its holdings in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after acquiring an additional 4,489,681 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares during the period. Finally, Russell Investments Group Ltd. boosted its stake in Acadia Healthcare by 21.4% in the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after acquiring an additional 3,248 shares during the period.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded down $0.89 during trading on Tuesday, reaching $20.60. The company had a trading volume of 4,816,671 shares, compared to its average volume of 1,562,702. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $1.90 billion, a PE ratio of 6.75, a price-to-earnings-growth ratio of 1.46 and a beta of 1.13. The firm's fifty day moving average is $30.57 and its 200 day moving average is $39.30.

Analyst Ratings Changes

Several brokerages recently issued reports on ACHC. Guggenheim initiated coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. Mizuho reduced their price target on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a report on Tuesday, March 25th. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Finally, StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $50.39.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.